Mirtazapine USP (Anhydrous) For Compounding (API)

Mirtazapine USP (Anhydrous) For Compounding (API) is an active pharmaceutical ingredient used in the treatment of major depressive disorder. As a noradrenergic and specific serotonergic antidepressant (NaSSA), it helps to balance neurotransmitters in the brain, improving mood and alleviating symptoms of depression. This API is essential in creating personalized medication formulations that may enhance patient outcomes by tailoring dosages to individual needs. Adhering to stringent quality standards, Mirtazapine plays a significant role in mental health management, offering a therapeutic option that supports emotional well-being and mental health recovery.

Mirtazapine USP (Anhydrous) active pharmaceutical ingredient (API) is a medication used for the treatment of major depressive disorder. It is classified as an antidepressant and works by affecting certain chemicals in the brain, such as serotonin and noradrenaline, that play a role in mood regulation.

Mirtazapine USP (Anhydrous) is the purified form of mirtazapine, which is a tetracyclic antidepressant. It is a white to creamy white crystal powder that is highly soluble in water.

Some of the most common side effects of Mirtazapine USP (Anhydrous) include drowsiness, dizziness, dry mouth, increased appetite, weight gain, and constipation. Less common but more serious side effects may include changes in heart rate, difficulty breathing, and seizures.

Mirtazapine USP (Anhydrous) must be prescribed by a licensed physician and should only be taken under the supervision of a medical professional. It is important to follow the prescribed dosage and inform the prescribing doctor about any other medications being taken, as well as any existing medical conditions.

As an API, Mirtazapine USP (Anhydrous) is the active component in the medication and is responsible for its therapeutic effects. It is also used in the production of generic versions of the medication, as it is the essential ingredient that provides the desired physiological effect.

There are different forms of mirtazapine available, including tablets, orally disintegrating tablets, and liquid formulations. These forms may contain different amounts of the API, but they all work in the same way to treat depression by balancing certain neurotransmitters in the brain.

Overall, Mirtazapine USP (Anhydrous) is an important and effective active ingredient in the treatment of major depressive disorder and should only be used as directed by a healthcare professional.

CAS Number: 85650-52-8

Property: Light Sensitive | Hazardous Material | Hygroscopic